| Patents for A61K 38 - Medicinal preparations containing peptides (316,240) |
|---|
| 07/12/2001 | CA2395198A1 Pp14 fusion proteins and methods for making and using the same |
| 07/12/2001 | CA2395132A1 Pharmaceutical formulations for the delivery of drugs having low aqueous solubility |
| 07/12/2001 | CA2394730A1 Novex polypeptides, nucleic acids encoding same and their diagnostic and therapeutic use |
| 07/12/2001 | CA2394184A1 Methods and compositions for mitigating pain using nitrate esters |
| 07/11/2001 | EP1114865A1 Production of human parathyroid hormone |
| 07/11/2001 | EP1114863A2 Heregulins (HRGs), binding proteins of P185erb2 |
| 07/11/2001 | EP1114862A2 Use of polyeptides or their encoding nucleic acids for the diagnosis or treatment of skin diseases and their use in indentifying pharmacologically acitve substances |
| 07/11/2001 | EP1114861A1 Ly6h gene |
| 07/11/2001 | EP1114829A2 Alloferons - Immunomodulatory peptides |
| 07/11/2001 | EP1114822A2 Indoles and tetrahydroisoquinolines containing alpha-keto oxadiazoles as serine protease inhibitors |
| 07/11/2001 | EP1114644A1 Composition comprising NPH insulin (neutral protamine hagedorn insulin) |
| 07/11/2001 | EP1114322A1 Tandem immuno-assay for cancer |
| 07/11/2001 | EP1114171A1 Methods for treatment of degenerative retinal diseases |
| 07/11/2001 | EP1114166A1 Method for down-regulating osteoprotegerin ligand activity |
| 07/11/2001 | EP1114164A1 Atp synthase subunit homolog |
| 07/11/2001 | EP1114160A1 Moraxella catarrhalis basb034 polypeptides and uses thereof |
| 07/11/2001 | EP1114159A1 Methods and compositions relating to egf-repeat-containing polypeptides |
| 07/11/2001 | EP1114158A2 Human cytoskeleton associated proteins |
| 07/11/2001 | EP1114156A2 Mammalian transforming growth factor beta - 9 (ztgfss9) |
| 07/11/2001 | EP1114155A2 Human gpcr proteins |
| 07/11/2001 | EP1114154A2 Compositions and methods for the treatment of immune related diseases |
| 07/11/2001 | EP1114153A2 Lynx, a novel family of receptor ligands in the central nervous system, corresponding nucleic acids and proteins and uses therof |
| 07/11/2001 | EP1114151A1 G protein-coupled receptor agonists or antagonists |
| 07/11/2001 | EP1114146A2 Human serine/threonine protein kinases |
| 07/11/2001 | EP1114145A1 Topa |
| 07/11/2001 | EP1114064A1 A monoclonal antibody against estrogen stimulated leucine aminopeptidase |
| 07/11/2001 | EP1114063A2 A method of producing a functional immunoglobulin superfamily protein |
| 07/11/2001 | EP1114061A1 FACTOR VIIa INHIBITORS |
| 07/11/2001 | EP1114060A1 Process for producing peptides from biological fluids and peptides obtainable by said process |
| 07/11/2001 | EP1114059A1 Regulation of immune responses by attractin |
| 07/11/2001 | EP1113821A1 In situ injection of antigen-presenting cells with genetically enhanced cytokine expression |
| 07/11/2001 | EP1113820A1 Expandible microparticle intracellular delivery system |
| 07/11/2001 | EP1113819A2 Antibody directed enzyme prodrug therapy (adept) with glucuronidase |
| 07/11/2001 | EP1113818A1 METHODS OF TREATING IgE-ASSOCIATED DISORDERS AND COMPOSITIONS FOR USE THEREIN |
| 07/11/2001 | EP1113813A1 Method of using zot or zonulin to inhibit lymphocyte proliferation in an antigen-specific manner |
| 07/11/2001 | EP1113812A1 Method and compositions for preventing or reducing hiv infection by use of inhibitors for leucine aminopeptidase |
| 07/11/2001 | EP1113811A1 Chemokine receptor antagonist and cyclosporin in combined therapy |
| 07/11/2001 | EP1113810A2 Methods of treating multiple myeloma and myeloma-induced bone resorption using integrin antagonists |
| 07/11/2001 | EP1113809A2 Pharmaceutical preparation containing a cyclopeptide and a chemotherapeutic agent or an angiogenesis inhibitor |
| 07/11/2001 | EP1113808A1 A method of treatment and agents useful for same |
| 07/11/2001 | EP1113807A2 Cell mediated gene delivery using muscle derived cells for treating muscle- and bone-related injury or dysfunction |
| 07/11/2001 | EP1113806A1 Anionic or cationic dendrimer antimicrobial or antiparasitic compositions |
| 07/11/2001 | EP1113801A1 METHOD FOR TREATING ATHEROSCLEROSIS EMPLOYING AN aP2 INHIBITOR AND COMBINATION |
| 07/11/2001 | EP1113800A1 Combinations of tetracyclic cyclic gmp-specific phosphodiesterase inhibitors with further therapeutic agents |
| 07/11/2001 | EP1113799A1 Protein formulations |
| 07/11/2001 | EP1113794A2 Methods of treating viral disease |
| 07/11/2001 | EP1113789A1 Method and composition for treatment of inflammatory bowel disease |
| 07/11/2001 | EP1007022B1 Preparation of a pulmonary surfactant for instillation and oral application |
| 07/11/2001 | EP0973872B1 Use of nerve growth factor for the storage, culture or treatment of cornea |
| 07/11/2001 | EP0969865A4 Mhc class ii antigen-presenting systems and methods for activating cd4?+ t cells |
| 07/11/2001 | EP0876371B1 Reverse-turn mimetics and methods relating thereto |
| 07/11/2001 | EP0822827A4 Antagonists of lhrh |
| 07/11/2001 | EP0794785B1 Growth factor expression in human pregnant cervix |
| 07/11/2001 | EP0760676B1 Materials and methods for treatment of plaquing diseases |
| 07/11/2001 | EP0735819B1 Cryptophycins |
| 07/11/2001 | EP0658112B1 A conjugate comprising a straight-chained polymer having bound sulphated glucosaminoglucans such as heparin, its preparation, use and a corresponding substrate |
| 07/11/2001 | EP0593516B1 Methods of treatment of motor neuron diseases using members of the bdnf/nt-3/ngf family of molecules |
| 07/11/2001 | EP0495064B1 Birch pollen allergen p14 for diagnosis and therapy of allergic diseases |
| 07/11/2001 | CN1303436A Compositions and methods for sensitizing and inhibiting growth of human tumor cells |
| 07/11/2001 | CN1303435A TAO protein kinases and methods of use therefor |
| 07/11/2001 | CN1303430A FAP alpha specific antibody with improved producibility |
| 07/11/2001 | CN1303429A Therapeutic applications of mature FLINT (mFLINT) polypeptides or OPG3, member of TNF receptor superfamily |
| 07/11/2001 | CN1303428A 人蛋白c多肽 Human protein peptide c |
| 07/11/2001 | CN1303394A Peptide compound for preventing and treating HIV infection and immunity diseases |
| 07/11/2001 | CN1303393A Specific binding molecules for scintigraphy, conjugates containing them and therapeutic method for treatment of angiogenesis |
| 07/11/2001 | CN1303381A Dipeptidyl peptidase IV effectors |
| 07/11/2001 | CN1303301A Use of anti-gp 39 antibodies for treatment and/or reversal of lupus and associated kidney disease |
| 07/11/2001 | CN1303300A Isolated peptides corresponding to amino acid sequences of NY-ESO-1, wherein bind to MHC class I and MHC class II molecules, and uses thereof |
| 07/11/2001 | CN1303299A Method and compositions for peptide synthesis |
| 07/11/2001 | CN1303298A Gene therapy approaches to supply apolipoprotein A-1 agonists and their use to treat dyslipidemic disorders |
| 07/11/2001 | CN1303288A Combination therapy for treatment of tumors |
| 07/11/2001 | CN1303274A Novel poly (methylidene malonate) microspheres, preparation method and pharmaceutical compositions containing them |
| 07/11/2001 | CN1303270A 气雾剂组合物 Aerosol composition |
| 07/11/2001 | CN1302901A Method for reproducing fly maggot with transgenic antibacterial peptide |
| 07/11/2001 | CN1302898A Polypeptide-human phosphatidase 14 and polynucleotide for coding it |
| 07/11/2001 | CN1302897A Polypeptide-human phosphodiesterase 21 similar to acidic sphingomyelinase and polynucleotide for coding it |
| 07/11/2001 | CN1302895A Human UDP glucose-glycoprotein glycosyl transferase and itscoding sequence |
| 07/11/2001 | CN1302894A Polypeptide-human dehydrogenase 35 and polynucleotide for coding it |
| 07/11/2001 | CN1302893A Polypeptide-human RNA uncoiling enzyme 44 and polynucleotide for coding it |
| 07/11/2001 | CN1302892A Polypeptide-human chondriosome acyl-CoA thioesterase 48 and polynucleotide for coding it |
| 07/11/2001 | CN1302889A Polypeptide-human protein 70 containing plasmolemma regulation function and polynucleotide for coding it |
| 07/11/2001 | CN1302888A Polypeptide-human rigor factor 23 and polynucleotide for coding it |
| 07/11/2001 | CN1302887A Polypeptide-dyein light-medium chain 58 and polynucleotide for coding it |
| 07/11/2001 | CN1302886A Polypeptide-human cell wither correlated protein 12 and polynucleotide for coding it |
| 07/11/2001 | CN1302884A Polypeptide-human eukaryote initiation factor 50 and polynucleotide for coding it |
| 07/11/2001 | CN1302883A Polypeptide-human enameling protein 23 and polynucleotide for coding it |
| 07/11/2001 | CN1302882A Polypeptide-human ankyrin 27 and polynucleotide for coding it |
| 07/11/2001 | CN1302881A Polypeptide-human beta-galactoside binding protein and polynucleotide for coding it |
| 07/11/2001 | CN1302880A Polypeptide-human shearing factor 25 and polynucleotide for coding it |
| 07/11/2001 | CN1302879A Polypeptide-human F-actin binding factor 75 and polynucleotide for coding it |
| 07/11/2001 | CN1302877A Polypeptide-human nuclein II precursor protein 25 and polynucleotide for coding it |
| 07/11/2001 | CN1302874A Polypeptide-translation initiation factor helper factor 28 and polynucleotide for coding it |
| 07/11/2001 | CN1302870A Human NADH ubiquinone oxido-reductase 20KD subunit and its coding sequence |
| 07/11/2001 | CN1302869A Polypeptide-NADP hydrogenase subunit 50 and polynucleotide for coding it |
| 07/11/2001 | CN1302868A Polypeptide-human F1F0 ATP synthetase subunit 15 and polynucleotide for coding it |
| 07/11/2001 | CN1302867A Polypeptide-human transposase 105 and polynucleotide for coding it |
| 07/11/2001 | CN1302817A Polypeptide-human S4 ribosomal protein 20 and polynucleotide for coding it |
| 07/11/2001 | CN1302816A Polypeptide-human DnaJ protein 42 and polynucleotide for coding it |
| 07/11/2001 | CN1302815A Polypeptide-human COP9 compound subunit 30 and polynucleotide for coding it |
| 07/11/2001 | CN1302812A Polypeptide-human RNA bindin 33 and polynucleotide for coding it |